These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8239604)

  • 1. Novel antibiotic regimens against Enterococcus faecium resistant to ampicillin, vancomycin, and gentamicin.
    Landman D; Mobarakai NK; Quale JM
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1904-8. PubMed ID: 8239604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of RPR 106972 alone and in combination with vancomycin, ampicillin, and gentamicin against multidrug-resistant enterococci.
    Messick CR; Woodward J; Pendland SL
    Diagn Microbiol Infect Dis; 1998 Oct; 32(2):95-9. PubMed ID: 9823531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unorthodox antibiotic combinations including ciprofloxacin against high-level gentamicin resistant enterococci.
    Tripodi MF; Utili R; Rambaldi A; Locatelli A; Rosario P; Florio A; Ruggiero G
    J Antimicrob Chemother; 1996 Apr; 37(4):727-36. PubMed ID: 8722538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of High-level Gentamicin Resistance among
    Labibzadeh M; Kaydani GA; Savari M; Ekrami A
    Pol J Microbiol; 2018; 67(4):401-406. PubMed ID: 30550226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bactericidal activities of antibiotics against vancomycin-resistant Enterococcus faecium blood isolates and synergistic activities of combinations.
    Hayden MK; Koenig GI; Trenholme GM
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1225-9. PubMed ID: 8092818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro synergistic activity of the combination of ampicillin and arbekacin against vancomycin-and high-level gentamicin-resistant Enterococcus faecium with the aph(2")-Id gene.
    Kak V; You I; Zervos MJ; Kariyama R; Kumon H; Chow JW
    Diagn Microbiol Infect Dis; 2000 Aug; 37(4):297-9. PubMed ID: 10974585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inconsistent bactericidal activity of triple-combination therapy with vancomycin, ampicillin, and gentamicin against vancomycin-resistant, highly ampicillin-resistant Enterococcus faecium.
    Fraimow HS; Venuti E
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1563-6. PubMed ID: 1510455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of resistance to ampicillin, gentamicin and vancomycin in Enterococcus faecalis and Enterococcus faecium isolates from clinical specimens and use of antimicrobials in five Nordic hospitals.
    Simonsen GS; Småbrekke L; Monnet DL; Sørensen TL; Møller JK; Kristinsson KG; Lagerqvist-Widh A; Torell E; Digranes A; Harthug S; Sundsfjord A
    J Antimicrob Chemother; 2003 Feb; 51(2):323-31. PubMed ID: 12562698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci.
    Louie A; Baltch AL; Ritz WJ; Smith RP; Asperilla M
    Chemotherapy; 1993; 39(5):302-9. PubMed ID: 8396526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of quinupristin/dalfopristin and other antibiotics against ampicillin-resistant enterococcus faecium.
    Wang FD; Liu IM; Liu CY
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):119-23. PubMed ID: 10677922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic treatment of experimental endocarditis due to vancomycin- and ampicillin-resistant Enterococcus faecium.
    Whitman MS; Pitsakis PG; Zausner A; Livornese LL; Osborne AJ; Johnson CC; Levison ME
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2069-73. PubMed ID: 8257125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation of high-level, gentamicin-resistant enterococci isolated from bacteremic patients.
    Wiland AM; Plaisance KI; Schwalbe RS
    Pharmacotherapy; 1994; 14(1):89-94. PubMed ID: 8159604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro activity of the combination of ampicillin and arbekacin against high-level gentamicin-resistant enterococci.
    Kariyama R; Kumon H; Chow L; Zervos MJ; Takata T; Tabata M; Chow JW
    J Antimicrob Chemother; 1998 Dec; 42(6):836-8. PubMed ID: 10052913
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful treatment of persistent bacteremia due to vancomycin-resistant, ampicillin-resistant Enterococcus faecium.
    Mekonen ET; Noskin GA; Hacek DM; Peterson LR
    Microb Drug Resist; 1995; 1(3):249-53. PubMed ID: 9158783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-kill profiles of Enterococcus to antibiotics used for intravitreal therapy.
    Kowalski RP; Karenchak LM; Warren BB; Eller AW
    Ophthalmic Surg Lasers; 1998 Apr; 29(4):295-9. PubMed ID: 9571661
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Brown Gandt A; Griffith EC; Lister IM; Billings LL; Han A; Tangallapally R; Zhao Y; Singh AP; Lee RE; LaFleur MD
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29784838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiologic evaluation of antimicrobial resistance in community-acquired enterococci.
    Silverman J; Thal LA; Perri MB; Bostic G; Zervos MJ
    J Clin Microbiol; 1998 Mar; 36(3):830-2. PubMed ID: 9508325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple-combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a moderately penicillin- and highly glycopeptide-resistant isolate of Enterococcus faecium.
    Caron F; Carbon C; Gutmann L
    J Infect Dis; 1991 Nov; 164(5):888-93. PubMed ID: 1940467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Class 1 Integron and In Vitro Effect of Antibiotic Combinations of Multidrug-Resistant
    Adeniji OO; Nontongana N; Okoh AI
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-kill study and synergistic activity of cell-wall inhibitor antibiotics in combination with gentamicin against Enterococcus faecalis and Enterococcus faecium.
    Aligholi M; Emaneini M; Taherikalani M; Shahsavan S; Jabalameli F; Asadollahi P; Khoramian B; Eslampour MA
    Acta Microbiol Immunol Hung; 2011 Sep; 58(3):219-26. PubMed ID: 21983323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.